Next Article in Journal
Pain Management in Pancreatic Cancer
Next Article in Special Issue
Doxorubicin-Loaded PEG-PCL-PEG Micelle Using Xenograft Model of Nude Mice: Effect of Multiple Administration of Micelle on the Suppression of Human Breast Cancer
Previous Article in Journal
The Role of Apoptosis in the Pathology of Pancreatic Cancer
Previous Article in Special Issue
A Comparative Study of Two Folate-Conjugated Gold Nanoparticles for Cancer Nanotechnology Applications
Open AccessReview

Clinically Relevant Anticancer Polymer Paclitaxel Therapeutics

by Danbo Yang 1, Lei Yu 1,2,* and Sang Van 2
1
Biomedical Engineering and Technology Institute, Institutes for Advanced Interdisciplinary Research, East China Normal University, 3663 North Zhongshan Road, Shanghai, 200062, China
2
Biomedical Group, Nitto Denko Technical Corporation, 501 Via Del Monte, Oceanside, CA 92058, USA
*
Author to whom correspondence should be addressed.
Cancers 2011, 3(1), 17-42; https://doi.org/10.3390/cancers3010017
Received: 12 November 2010 / Revised: 10 December 2010 / Accepted: 22 December 2010 / Published: 23 December 2010
(This article belongs to the Special Issue Nanotechnology and Cancer Therapeutics)
The concept of utilizing polymers in drug delivery has been extensively explored for improving the therapeutic index of small molecule drugs. In general, polymers can be used as polymer-drug conjugates or polymeric micelles. Each unique application mandates its own chemistry and controlled release of active drugs. Each polymer exhibits its own intrinsic issues providing the advantage of flexibility. However, none have as yet been approved by the U.S. Food and Drug Administration. General aspects of polymer and nano-particle therapeutics have been reviewed. Here we focus this review on specific clinically relevant anticancer polymer paclitaxel therapeutics. We emphasize their chemistry and formulation, in vitro activity on some human cancer cell lines, plasma pharmacokinetics and tumor accumulation, in vivo efficacy, and clinical outcomes. Furthermore, we include a short review of our recent developments of a novel poly(L-g-glutamylglutamine)-paclitaxel nano-conjugate (PGG-PTX). PGG-PTX has its own unique property of forming nano-particles. It has also been shown to possess a favorable profile of pharmacokinetics and to exhibit efficacious potency. This review might shed light on designing new and better polymer paclitaxel therapeutics for potential anticancer applications in the clinic. View Full-Text
Keywords: polymer paclitaxel therapeutics; polymeric micelles; polymer paclitaxel conjugates polymer paclitaxel therapeutics; polymeric micelles; polymer paclitaxel conjugates
MDPI and ACS Style

Yang, D.; Yu, L.; Van, S. Clinically Relevant Anticancer Polymer Paclitaxel Therapeutics. Cancers 2011, 3, 17-42.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop